Kurzporträt
Mitarbeiterzahl: 128
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 58 | 20.03.17 |
David Kirske
DFI | Director of Finance/CFO | 69 | 01.08.17 |
John Volpone
HRO | Human Resources Officer | - | - |
Jim Fong
PRN | Corporate Officer/Principal | 62 | 01.01.08 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 58 | 20.03.17 |
David Parkinson
BRD | Director/Board Member | 73 | 05.06.17 |
Reed Tuckson
BRD | Director/Board Member | 73 | 01.09.11 |
Diane Parks
BRD | Director/Board Member | 71 | 24.08.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 0 | 3 047 | 0 | 0 | 95,47 % |
Aktie B | 1 | 131 880 176 | 125 911 110 ( 95,47 %) | 0 |
Unternehmenskontakt
CTI BioPharma Corp.
3101 Western Avenue Suite 800
98121, Seattle
+206 282 7100
http://www.ctibiopharma.com![Straße CTI BioPharma Corp.(CTIC)](https://cdn.zonebourse.com/static/address/32713095.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+34.14% | 51.12 Mrd. | |
-6.54% | 39.4 Mrd. | |
+34.92% | 38.48 Mrd. | |
+12.62% | 26.36 Mrd. | |
-12.11% | 26.22 Mrd. | |
-13.43% | 20.96 Mrd. | |
+43.73% | 14.02 Mrd. | |
+31.81% | 12.49 Mrd. | |
-4.54% | 11.61 Mrd. |